Population
Preclinical in vivo model and renal homogenates
Design
Preclinical
Authors
Loading...
Supports NADPH oxidase mediation of Ang II renal effects in rodents; leaves open translation to human hypertension therapies.
Angiotensin II's acute renal vasoconstrictor and antinatriuretic effects are partially mediated by NADPH oxidase-dependent superoxide generation, which reduces nitric oxide bioavailability.
Andrade et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: